InsightfulValue
← Home

Merck
Merck

-4.8%

Pharma / Pharma


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

More reviews (1)
Merck

πŸ“Š Get full analytics about Merck

Sign up for free or log in

πŸ“ Join us and grab your copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Infographic
Infographics
Overview
Merck is a global pharmaceutical and chemical company founded in 1668 in Darmstadt, Germany. It was originally a supplier of traditional chemicals, but later expanded into pharmaceuticals, life sciences, and performance materials. Merck is also known as Merck KGaA, as it is a family-owned company with around 50% of its shares controlled by the descendants of its founder, Friedrich Jacob Merck.
The company has a strong presence in Europe and the United States, as well as in emerging markets such as China, India, and Latin America. It employs over 57,000 people and generates annual revenues of around 14 billion euros.
Merck's pharmaceutical division focuses on developing and commercializing innovative medicines in various therapeutic areas, including oncology, neurology, immunology, and cardiovascular diseases. Its life sciences division provides products and services for research, development, and production in the biopharmaceutical and biotechnological industries. The performance materials division provides materials and technologies for various industries, including healthcare, electronics, coatings, and cosmetics.
The company's mission is to "empower scientists and engineers to create and make life-changing innovations that improve people's lives." It is committed to sustainability and has set ambitious targets to reduce its environmental impact, promote diversity and inclusion, and improve access to healthcare for underserved populations.
Merck is also actively involved in corporate social responsibility initiatives, including providing disaster relief and supporting education and community development programs around the world.
How to explain to a 10 year old kid about the company?
Merck

πŸ“ˆ Want to read more about Merck?

Sign up for free or log in

πŸ“š Your free copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" is waiting

TWVyY2sgaX MgYSBiaWcg Y29tcGFueS B0aGF0IGhl bHBzIHBlb3 BsZSBzdGF5 IGhlYWx0aH kuIEltYWdp bmUgaXQgbG lrZSBhIHN1 cGVyaGVyby Bmb3IgaGVh bHRoISBUaG V5IGNyZWF0 ZSBtZWRpY2 luZXMgYW5k IHZhY2Npbm VzIHRoYXQg aGVscCBmaW dodCBvZmYg ZGlzZWFzZX MsIHdoaWNo IGlzIHZlcn kgaW1wb3J0 YW50IGZvci BrZWVwaW5n IHBlb3BsZS BzYWZlIGFu ZCB3ZWxsLi A8YnI+U28s IGhvdyBkb2 VzIE1lcmNr IG1ha2UgbW 9uZXk/IFdo ZW4gZG9jdG 9ycyBhbmQg aG9zcGl0YW xzIHVzZSB0 aGVpciBtZW RpY2luZXMg YW5kIHZhY2 NpbmVzIHRv IGhlbHAgcG F0aWVudHMs IHRoZXkgcG F5IE1lcmNr IGZvciB0aG VtLiBJdOKA mXMga2luZC BvZiBsaWtl IGhvdyB5b3 UgYnV5IGEg dG95IGZyb2 0gYSBzdG9y ZS4gVGhlIG 1vcmUgcGVv cGxlIHRoYX QgbmVlZCB0 aGVpciBtZW RpY2luZXMs IHRoZSBtb3 JlIG1vbmV5 IHRoZSBjb2 1wYW55IG1h a2VzLjxicj 5Ob3csIHdo eSBpcyBNZX JjayBzdWNj ZXNzZnVsPy BXZWxsLCB0 aGV5IGRvIG EgbG90IG9m IHJlc2Vhcm NoIHRvIGRp c2NvdmVyIG 5ldyBtZWRp Y2luZXMgdG hhdCBjYW4g aGVscCB3aX RoIGRpZmZl cmVudCBoZW FsdGggcHJv YmxlbXMuIF RoZXkgYWxz byB0cnkgdG 8gbWFrZSBz dXJlIHRoZW lyIHByb2R1 Y3RzIGFyZS BzYWZlIGFu ZCBlZmZlY3 RpdmUgZm9y IGV2ZXJ5b2 5lLiBQbHVz LCBhcyBtb3 JlIHBlb3Bs ZSBpbiB0aG Ugd29ybGQg bmVlZCBoZW FsdGhjYXJl LCBNZXJja+ KAmXMgd29y ayBiZWNvbW VzIG1vcmUg aW1wb3J0YW 50Ljxicj5B cyBmb3IgdG hlIGZ1dHVy ZSwgTWVyY2 sgaXMgbGlr ZWx5IHRvIH N0YXkgc3Vj Y2Vzc2Z1bC BiZWNhdXNl IHRoZXkgYX JlIGFsd2F5 cyB3b3JraW 5nIG9uIG5l dyBpZGVhcy BhbmQgdHJl YXRtZW50cy 4gVGhleSBp bnZlc3QgYS Bsb3QgaW4g c2NpZW5jZS BhbmQgaW5u b3ZhdGlvbi wgd2hpY2gg bWVhbnMgdG hleSBhcmUg YWx3YXlzIG xvb2tpbmcg Zm9yIGJldH RlciB3YXlz IHRvIGhlbH AgcGVvcGxl LiBBbmQgd2 l0aCBuZXcg Y2hhbGxlbm dlcywgbGlr ZSBuZXcgZG lzZWFzZXMs IHRoZXJlIH dpbGwgYWx3 YXlzIGJlIG EgbmVlZCBm b3IgZ29vZC BtZWRpY2lu ZXMsIHNvIE 1lcmNrIHdp bGwga2VlcC BwbGF5aW5n IGEga2V5IH JvbGUgaW4g aGVhbHRoIG NhcmUuPGJy Pg==
What is special about the company?
Merck

πŸ“ˆ Want to read more about Merck?

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

TWVyY2sgaX MgYSBnbG9i YWwgcGhhcm 1hY2V1dGlj YWwgYW5kIG hlYWx0aGNh cmUgY29tcG FueSB0aGF0 IGhhcyBiZW VuIGluIG9w ZXJhdGlvbi Bmb3Igb3Zl ciAzNTAgeW VhcnMsIG1h a2luZyBpdC BvbmUgb2Yg dGhlIG9sZG VzdCBhbmQg bGFyZ2VzdC BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMgaW4gdG hlIHdvcmxk LiBJdCBoYX MgYSBsb25n IGhpc3Rvcn kgb2YgaW5u b3ZhdGlvbi BhbmQgcmVz ZWFyY2gsIG xlYWRpbmcg dG8gdGhlIG RldmVsb3Bt ZW50IG9mIG 51bWVyb3Vz IG1lZGljYX Rpb25zIGFu ZCB2YWNjaW 5lcyB0aGF0 IGhhdmUgc2 lnbmlmaWNh bnRseSBpbX Byb3ZlZCBn bG9iYWwgaG VhbHRoLiBU aGUgY29tcG FueSBhbHNv IGhhcyBhIH N0cm9uZyBj b21taXRtZW 50IHRvIHN1 c3RhaW5hYm lsaXR5IGFu ZCBjb3Jwb3 JhdGUgcmVz cG9uc2liaW xpdHksIGVt cGhhc2l6aW 5nIGV0aGlj YWwgYnVzaW 5lc3MgcHJh Y3RpY2VzIG FuZCBnaXZp bmcgYmFjay B0byB0aGUg Y29tbXVuaX RpZXMgaW4g d2hpY2ggaX Qgb3BlcmF0 ZXMuIE1lcm NrIGlzIGFs c28ga25vd2 4gZm9yIGl0 cyBkaXZlcn NlIHdvcmtm b3JjZSBhbm QgaW5jbHVz aXZlIGN1bH R1cmUsIHdp dGggYSBmb2 N1cyBvbiBw cm9tb3Rpbm cgZGl2ZXJz aXR5IGFuZC BpbmNsdXNp b24gaW4gYW xsIGFzcGVj dHMgb2YgaX RzIG9wZXJh dGlvbnMuIE FkZGl0aW9u YWxseSwgTW VyY2sgaGFz IGEgc3Ryb2 5nIGZvY3Vz IG9uIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBh bmQgaW52ZX N0cyBoZWF2 aWx5IGluIG 5ldyB0ZWNo bm9sb2dpZX MgYW5kIGlu bm92YXRpb2 5zIHRvIGNv bnRpbnVlIG RyaXZpbmcg c2NpZW50aW ZpYyBhZHZh bmNlbWVudH MgaW4gdGhl IGhlYWx0aG NhcmUgaW5k dXN0cnkuIE 92ZXJhbGws IE1lcmNrJ3 MgZGVkaWNh dGlvbiB0by BpbXByb3Zp bmcgZ2xvYm FsIGhlYWx0 aCwgY29tbW l0bWVudCB0 byBldGhpY2 FsIGFuZCBy ZXNwb25zaW JsZSBidXNp bmVzcyBwcm FjdGljZXMs IGFuZCBlbX BoYXNpcyBv biBkaXZlcn NpdHkgYW5k IHJlc2Vhcm NoIG1ha2Ug aXQgYSB1bm lxdWUgYW5k IHJlc3BlY3 RlZCBjb21w YW55IGluIH RoZSBwaGFy bWFjZXV0aW NhbCBpbmR1 c3RyeS4=
What the company's business model?
Merck

πŸ“ˆ Want to read more about Merck?

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

VGhlIE1lcm NrIGNvbXBh bnkgaXMgYS BnbG9iYWwg cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B0aGF0IG9w ZXJhdGVzIH VuZGVyIGEg dHJhZGl0aW 9uYWwgYnVz aW5lc3MgbW 9kZWwuIFRo aXMgbWVhbn MgdGhhdCBp dCBjcmVhdG VzLCBtYW51 ZmFjdHVyZX MsIGFuZCBt YXJrZXRzIH ByZXNjcmlw dGlvbiBkcn VncywgdmFj Y2luZXMsIG Jpb2xvZ2lj IHRoZXJhcG llcywgYW5p bWFsIGhlYW x0aCBwcm9k dWN0cywgYW 5kIG92ZXIt dGhlLWNvdW 50ZXIgbWVk aWNhdGlvbn MuIFRoZSBj b21wYW55J3 MgbWFpbiBy ZXZlbnVlIH NvdXJjZSBp cyB0aHJvdW doIHRoZSBz YWxlIG9mIH RoZXNlIHBy b2R1Y3RzIH RvIGhlYWx0 aCBjYXJlIH Byb2Zlc3Np b25hbHMgYW 5kIGRpcmVj dGx5IHRvIG NvbnN1bWVy cy4gTWVyY2 sgYWxzbyBl bmdhZ2VzIG luIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCBvZi BuZXcgbWVk aWNpbmVzLC BhbmQgaGFz IGEgbGFyZ2 UgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz IGZvY3VzZW Qgb24gdGhl cmFwZXV0aW MgYXJlYXMg c3VjaCBhcy BvbmNvbG9n eSwgY2FyZG lvdmFzY3Vs YXIgZGlzZW FzZXMsIHZh Y2NpbmVzLC BpbmZlY3Rp b3VzIGRpc2 Vhc2VzLCBh bmQgYW5pbW FsIGhlYWx0 aC4gSW4gYW RkaXRpb24g dG8gZGV2ZW xvcGluZyBh bmQgc2VsbG luZyBpdHMg b3duIHByb2 R1Y3RzLCBN ZXJjayBhbH NvIGVuZ2Fn ZXMgaW4gcG FydG5lcnNo aXBzIGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIG90 aGVyIGNvbX BhbmllcyBp biB0aGUgaG VhbHRoY2Fy ZSBpbmR1c3 RyeS4=
Is AI a threat?
AI can impact Merck and its competitive positioning across various dimensions, though the extent of the threat can vary based on specific circumstances.
1. Substitution: AI technologies can potentially lead to the development of new products or therapies that offer alternative solutions to traditional pharmaceuticals. For example, AI-driven drug discovery platforms can identify novel compounds faster and more efficiently than traditional methods. If competitors successfully leverage AI to develop more effective treatments, Merck could face pressure on its product offerings.
2. Disintermediation: AI can streamline processes and reduce the need for certain intermediaries in the healthcare supply chain. For instance, telemedicine and digital health platforms can create direct interactions between patients and healthcare providers, bypassing traditional routes. If patients increasingly rely on AI-driven solutions for diagnosis and treatment recommendations, Merck might see shifts in how its products are marketed and accessed.
3. Margin Pressure: The use of AI in drug development and manufacturing can lead to cost reductions, which may create margin pressure for established pharmaceutical companies like Merck. If competitors utilize AI to produce similar products at a lower cost or bring drugs to market more quickly, Merck may need to adjust its pricing strategy or invest in technology to maintain its margins.
Overall, while AI does pose potential threats to Merck regarding substitution, disintermediation, and margin pressure, it can also represent an opportunity for the company to enhance its own capabilities, drive innovation, and improve efficiencies across its operations. The net effect will depend on how well Merck adapts and integrates AI into its strategies.
Sensitivity to interest rates
The sensitivity of Merck & Co.’s earnings, cash flow, and valuation to changes in interest rates can be analyzed through several factors:
1. Earnings Sensitivity: Merck’s earnings are indirectly sensitive to interest rates. Higher interest rates can lead to increased borrowing costs if the company needs to finance operations, research and development, or acquisitions. Additionally, higher rates may constrain consumer spending, potentially impacting sales of pharmaceuticals. Conversely, lower interest rates may facilitate capital investment and expansion.
2. Cash Flow Sensitivity: Merck’s cash flow can be affected by interest rates primarily through its debt obligations. If interest rates rise, the cost of servicing any variable-rate debt will increase, potentially reducing free cash flow. Lower rates can positively impact cash flow by lowering interest expenses. Moreover, changes in interest rates can influence the timing and amount of cash flows received from customers, especially in a tight economic environment.
3. Valuation Sensitivity: The valuation of Merck, like other companies, is sensitive to changes in interest rates due to the discounted cash flow (DCF) methodology generally used to estimate a company’s value. When interest rates rise, the discount rate used in DCF calculations increases, which can lead to a lower present value of future cash flows, thus reducing the company’s valuation. Conversely, lower interest rates can enhance valuation by lowering the discount rate and increasing the present value of future cash flows.
In summary, while Merck’s operations can be influenced by changes in interest rates, the sensitivity may not be as pronounced as in highly leveraged companies. The impact on earnings, cash flow, and valuation will depend on the company’s debt levels, capital structure, and market dynamics.
Resilience to the future changes
Merck

πŸ“ˆ Want to read more about Merck?

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgTW VyY2vigJlz IGVjb25vbW ljcyBvdmVy IHRoZSBuZX h0IDMtNSB5 ZWFycyBpcy B0aGUgbG9z cyBvZiBwYX RlbnQgcHJv dGVjdGlvbi Bmb3IgaXRz IGtleSBkcn VncywgcGFy dGljdWxhcm x5IEtleXRy dWRhLCBpdH MgbGVhZGlu ZyBpbW11bm 8tb25jb2xv Z3kgdHJlYX RtZW50LiBJ ZiBLZXl0cn VkYSBsb3Nl cyBwYXRlbn QgcHJvdGVj dGlvbiBhbm QgZmFjZXMg cm9idXN0IG dlbmVyaWMg Y29tcGV0aX Rpb24gc29v bmVyIHRoYW 4gYW50aWNp cGF0ZWQsIE 1lcmNrIG1h eSBleHBlcm llbmNlIGEg c2lnbmlmaW NhbnQgZHJv cCBpbiByZX ZlbnVlLiBB ZGRpdGlvbm FsbHksIGlm IG5ldyBlbn RyYW50cyBp biB0aGUgb2 5jb2xvZ3kg bWFya2V0IG FyZSBhYmxl IHRvIG9mZm VyIGVxdWl2 YWxlbnQgb3 Igc3VwZXJp b3IgdGhlcm FwaWVzIGF0 IGEgbG93ZX IgY29zdCwg dGhpcyBjb3 VsZCBmdXJ0 aGVyIGVyb2 RlIE1lcmNr 4oCZcyBtYX JrZXQgc2hh cmUuPGJyPk luIHRoaXMg c2NlbmFyaW 8sIE1lcmNr 4oCZcyBtYX JnaW5zIHdv dWxkIGJlIG FkdmVyc2Vs eSBhZmZlY3 RlZC4gVGhl IGNvbXBhbn kgbWlnaHQg c2VlIGl0cy Bncm9zcyBt YXJnaW4gZG VjbGluZSBh cyBpdCBhZG p1c3RzIHBy aWNpbmcgc3 RyYXRlZ2ll cyB0byBjb2 1wZXRlIHdp dGggZ2VuZX JpY3MsIHdo aWxlIGFsc2 8gaW5jdXJy aW5nIGNvc3 RzIGFzc29j aWF0ZWQgd2 l0aCBtYWlu dGFpbmluZy BtYXJrZXQg cHJlc2VuY2 UgdGhyb3Vn aCBkaXNjb3 VudHMgYW5k IHJlYmF0ZX MuIE9wZXJh dGluZyBtYX JnaW5zIHdv dWxkIGJlIH NxdWVlemVk IGFzIHdlbG wsIHJlZmxl Y3RpbmcgYS BuZWVkIHRv IGludmVzdC BoZWF2aWx5 IGluIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCB0 byByZXBsYW NlIGxvc3Qg cmV2ZW51ZS BzdHJlYW1z IGFuZCB0by BlbmhhbmNl IG1hcmtldG luZyBlZmZv cnRzIHRvIH N0aW11bGF0 ZSBleGlzdG luZyBwcm9k dWN0cy48Yn I+Q2FzaCBm bG93IHdvdW xkIGxpa2Vs eSBkZXRlcm lvcmF0ZSBz aWduaWZpY2 FudGx5LiBB IHNoYXJwIG RlY3JlYXNl IGluIHNhbG VzIGZyb20g S2V5dHJ1ZG EgY291bGQg bGVhZCB0by BvcGVyYXRp b25hbCBjYX NoIGZsb3cg ZHJvcHBpbm cgc3Vic3Rh bnRpYWxseS wgbGltaXRp bmcgdGhlIG FiaWxpdHkg dG8gaW52ZX N0IGluIG5l dyBwcm9kdW N0cyBvciBp bml0aWF0aX Zlcy4gSWYg dGhlIGNhc2 ggZmxvdyBp cyBpbnN1Zm ZpY2llbnQg dG8gbWVldC BvYmxpZ2F0 aW9ucywgTW VyY2sgbWln aHQgcmVzb3 J0IHRvIGlu Y3JlYXNlZC Bib3Jyb3dp bmcgb3IgY3 V0dGluZyBk b3duIG9uIG NhcGl0YWwg ZXhwZW5kaX R1cmVzLCBm dXJ0aGVyIH N0cmFpbmlu ZyBpdHMgZm luYW5jaWFs IHBvc2l0aW 9uLjxicj5P biB0aGUgYm FsYW5jZSBz aGVldCwgTW VyY2sgY291 bGQgc2VlIG EgbWFya2Vk IGluY3JlYX NlIGluIGxp YWJpbGl0aW VzIGlmIHRo ZXkgdG9vay BvbiBhZGRp dGlvbmFsIG RlYnQgdG8g bWFuYWdlIG Nhc2ggZmxv dyBpc3N1ZX MuIFRoaXMg d291bGQgcm Fpc2UgdGhl aXIgZGVidC 10by1lcXVp dHkgcmF0aW 8sIGluZGlj YXRpbmcgaW 5jcmVhc2Vk IGZpbmFuY2 lhbCByaXNr LiBNZWFud2 hpbGUsIHJl dGFpbmVkIG Vhcm5pbmdz IG1pZ2h0IG RlY3JlYXNl IGFzIHRoZS Bjb21wYW55 IHN0cnVnZ2 xlcyB0byBt YWludGFpbi Bwcm9maXRh YmlsaXR5LC B3aGljaCBj b3VsZCBhZm ZlY3Qgc2hh cmVob2xkZX IgZXF1aXR5 IGFuZCBvdm VyYWxsIGZp bmFuY2lhbC BzdGFiaWxp dHkuPGJyPk 92ZXJhbGws IHN1Y2ggYS BzY2VuYXJp byBjb3VsZC BsZWFkIHRv IGEgZGltaW 5pc2hlZCBj b21wZXRpdG l2ZSBwb3Np dGlvbiBmb3 IgTWVyY2ss IGEgbW9yZS B2b2xhdGls ZSBlYXJuaW 5ncyBwcm9m aWxlLCBhbm QgYSBwb3Rl bnRpYWxseS BuZWdhdGl2 ZSBwZXJjZX B0aW9uIGlu IHRoZSBtYX JrZXQsIGlt cGFjdGluZy BzdG9jayBw ZXJmb3JtYW 5jZSBhbmQg aW52ZXN0b3 IgY29uZmlk ZW5jZS48Yn I+
Interesting facts about the company
Merck

πŸ“ˆ Want to read more about Merck?

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvNX owZmx5ZTJB cEZ0SVRRMD FCZFkud2Vi cCIgYWx0PS JNZXJjayIg dGl0bGU9Ik 1lcmNrIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTUwIHdp ZHRoPTUwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE 1lcmNrPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +SoSBMZWFy biBzbWFydG VyIHN0b2Nr IHBpY2tzIH dpdGggPGk+ IlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3MiPC9pPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8IS0tCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxkaXYgc3 R5bGU9J21h cmdpbi10b3 A6IDEycHg7 IGZvbnQtc2 l6ZTogMTNw eDsgY29sb3 I6ICM0NDQ7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IFNpZ24gdX Agbm93IGFu ZCBnZXQgb3 VyIGZyZWUg ZUJvb2sgCi AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICA8Yj 5UaGUgQ2hl Y2tsaXN0IF ZhbHVlIElu dmVzdG9yIO KAlCBBIFNt YXJ0ZXIgV2 F5IHRvIFBp Y2sgU3RvY2 tzPC9iPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgLS0+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID whLS0KICAg ICAgICAgIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nbWFyZ2 luLXRvcDog MTZweDsgZm 9udC1zaXpl OiAxNHB4Oy Bjb2xvcjog IzQ0NDsgZm 9udC1mYW1p bHk6IC1hcH BsZS1zeXN0 ZW0sIEJsaW 5rTWFjU3lz dGVtRm9udC wgU2Vnb2Ug VUksIFJvYm 90bywgSGVs dmV0aWNhIE 5ldWUsIHNh bnMtc2VyaW Y7IGxpbmUt aGVpZ2h0Oi AxLjY7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIEhh dmUgeW91IG hlYXJkIGFi b3V0IG91ci BzaG9ydCA8 c3Ryb25nIH N0eWxlPSdm b250LXdlaW dodDogNjAw Oyc+RGFpbH kgVmlkZW8g TmV3c2xldH Rlcjwvc3Ry b25nPj8KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDxhIG hyZWY9J2h0 dHBzOi8vd3 d3Lmluc2ln aHRmdWx2YW x1ZS5jb20v bmV3c2xldH Rlci5waHAn IHRhcmdldD 0nX2JsYW5r JyBzdHlsZT 0nY29sb3I6 ICMwMDdCRk Y7IHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsgZm9udC 13ZWlnaHQ6 IDUwMDsgbW FyZ2luLWxl ZnQ6IDZweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIEZp bmQgb3V0IG 1vcmUKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIC0tPgog ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAKIC AgICAgICAK ICAgICAgIC A8c3BhbiBj bGFzcz0nYm x1cnJlZC10 ZXh0Jz4KIC AgICAgICAg ICAgVFdWeV kyc2dKbSBG dGNEc2dRMj h1IExDQnJi bTkzYmkgQm hjeUJOVTBR ZyBiM1YwYz Jsa1pTIEIw YUdVZ1ZXNX AgZEdWa0lG TjBZWCBSbG N5QmhibVFn IFEyRnVZV1 JoTEMgQnBj eUJ2Ym1VZy BiMllnZEdo bElHIHhoY2 1kbGMzUWcg Y0doaGNtMW hZMiBWMWRH bGpZV3dnIF kyOXRjR0Z1 YVcgVnpJR2 x1SUhSbyBa U0IzYjNKc1 pDIDRnU0dW eVpTQmggY2 1VZ2MyOXRa UyBCcGJuUm xjbVZ6IGRH bHVaeUJtWV cgTjBjeUJo WW05MSBkQ0 IwYUdVZ1ky IDl0Y0dGdW VUbzggWW5J K01TNGdTRy BsemRHOXll VG9nIFRXVn lZMnNnZDIg RnpJRzl5YV dkcCBibUZz YkhrZ1ptID kxYm1SbFpD QnAgYmlBeE 9Ea3hJRyBG eklIUm9aU0 JWIExsTXVJ SE4xWW4gTn BaR2xoY25r ZyBiMllnZE dobElFIGRs Y20xaGJpQk 4gWlhKamF5 Qm1ZVyAxcG JIa2dZMjl0 IGNHRnVlU3 dnZDIgaHBZ MmdnWkdGMC BaWE1nWW1G amF5IEIwYn lBeE5qWTQg TGlCVWFHVW dWUyA1VExp QmljbUZ1IF kyZ2dZbVZq WVcgMWxJR2 x1WkdWdyBa VzVrWlc1ME lHIFIxY21s dVp5QlggYj NKc1pDQlhZ WCBJZ1NTND hZbkkrIE1p NGdTVzV1Yj MgWmhkR2x2 YmpvZyBUV1 Z5WTJzZ2FH IEZ6SUdKbF pXNGcgY21W emNHOXVjMi BsaWJHVWda bTl5IElITm xkbVZ5WVcg d2daM0p2ZF c1ayBZbkps WVd0cGJtIG NnWkhKMVoz TWcgWVc1a0 lIWmhZMiBO cGJtVnpJRz kyIFpYSWdk R2hsSUggbG xZWEp6TENC cCBibU5zZF dScGJtIGNn ZEdobElHUm wgZG1Wc2Iz QnRaVyA1ME lHOW1JSFJv IFpTQm1hWE p6ZEMgQnRa V0Z6YkdWei BJSFpoWTJO cGJtIFVnYV c0Z2RHaGwg SURFNU5qQn pMQyBCMGFH VWdTRkJXIE lIWmhZMk5w Ym0gVWdSMk Z5WkdGeiBh V3dzSUdGdV pDIEIwYUdV Z1kyaHYgYk dWemRHVnli MiB3dGJHOT NaWEpwIGJt Y2daSEoxWn kgQmFiMk52 Y2k0OCBZbk krTXk0Z1Vt IFZ6WldGeV kyZ2cgUm05 amRYTTZJRS AxbGNtTnJJ R2x1IGRtVn pkSE1nYUcg VmhkbWxzZV NCcCBiaUJ5 WlhObFlYIE pqYUNCaGJt UWcgWkdWMl pXeHZjRyAx bGJuUXVJRl JvIFpTQmpi MjF3WVcgNT VJR2hoY3lC aCBJR3h2Ym 1jdGMzIFJo Ym1ScGJtY2 cgWTI5dGJX bDBiVyBWdW RDQjBieUJo IFpIWmhibU 5wYm0gY2dh R1ZoYkhSby BZMkZ5WlNC MGFIIEp2ZF dkb0lITmog YVdWdVkyVW dZVyA1a0lH aGhjeUJoIE lHUnBkbVZ5 YzIgVWdjR2 x3Wld4cCBi bVVnZEdoaG RDIEJwYm1O c2RXUmwgY3 lCMGNtVmhk RyAxbGJuUn pJR1p2IGNp QmthV0ZpWl ggUmxjeXdn WTJGdSBZMl Z5TENCaGJt IFFnYVc1bV pXTjAgYVc5 MWN5QmthWC BObFlYTmxj eTQ4IFluSS tOQzRnUjIg eHZZbUZzSU ZKbCBZV05v T2lCTlpYIE pqYXlCdmNH VnkgWVhSbG N5QnBiaSBC dGIzSmxJSF JvIFlXNGdN VFF3SUcgTn ZkVzUwY21s bCBjeXdnYl dGcmFXIDVu SUdsMGN5Qn cgY205a2RX TjBjeSBCaF kyTmxjM05w IFlteGxJSF J2SUcgRWdj MmxuYm1sbS BhV05oYm5R Z2NHIDl5ZE dsdmJpQnYg WmlCMGFHVW daMiB4dllt RnNJSEJ2IG NIVnNZWFJw YjIgNHVJRW wwY3lCbiBi RzlpWVd3Z2 NIIEpsYzJW dVkyVWcgWV d4c2IzZHpJ RyBadmNpQm thWFpsIGNu TmxJRzFoY2 0gdGxkSE1n WVc1ayBJSE JoY25SdVpY IEp6YUdsd2 N5NDggWW5J K05TNGdRMi A5dGJXbDBi V1Z1IGRDQj BieUJUZFgg TjBZV2x1WV dKcCBiR2ww ZVRvZ1RXIF Z5WTJzZ2FH RnogSUcxaF pHVWdjMyBS eWFXUmxjeU JwIGJpQnpk WE4wWVcgbH VZV0pzWlNC dyBjbUZqZE dsalpYIE1z SUdGcGJXbH UgWnlCMGJ5 QnlaVyBSMV kyVWdhWFJ6 IElHVnVkbW x5YjIgNXRa VzUwWVd3Zy BabTl2ZEhC eWFXIDUwSU dGdVpDQm0g YjJOMWMybH VaeSBCdmJp QnlaWE53IG IyNXphV0pz WlMgQnpiM1 Z5WTJsdSBa eXdnWlc1bG NtIGQ1SUdW bVptbGogYV dWdVkza3NJ RyBGdVpDQj NZWE4wIFpT QnlaV1IxWT MgUnBiMjRn YVc0ZyBhWF J6SUcxaGJu IFZtWVdOMG RYSnAgYm1j Z2NISnZZMi BWemMyVnpM anhpIGNqND JMaUJOWlgg SmpheUJOWV c1MSBZV3c2 SUUxbGNtIE 5ySUhCMVlt eHAgYzJobG N5QjBhRyBV Z1RXVnlZMn NnIFRXRnVk V0ZzTEMgQm hJSGRwWkdW cyBlU0J5Wl hOd1pXIE4w WldRZ2JXVm sgYVdOaGJD QnlaVyBabG NtVnVZMlVn IFltOXZheU IxYzIgVmtJ R0o1SUdobC BZV3gwYUdO aGNtIFVnY0 hKdlptVnog YzJsdmJtRn NjeSA0Z1NY UWdhR0Z6IE lHSmxaVzRn YVcgNGdjSF ZpYkdsaiBZ WFJwYjI0Z2 MyIGx1WTJV Z01UZzUgT1 NCaGJtUWdh WCBNZ1lYWm hhV3hoIFlt eGxJR2x1SU cgMTFiSFJw Y0d4bCBJR3 hoYm1kMVlX IGRsY3k0OF luSSsgTnk0 Z1EyOXljRy A5eVlYUmxJ Rk52IFkybG hiQ0JTWlgg TndiMjV6YV dKcCBiR2ww ZVRvZ1RXIF Z5WTJzZ2FY TWcgYVc1Mm IyeDJaVyBR Z2FXNGdkbU Z5IGFXOTFj eUJ3YUcgbH NZVzUwYUhK diBjR2xqSU dsdWFYIFJw WVhScGRtVn ogTENCcGJt TnNkVyBScG JtY2dZV05q IFpYTnpJSF J2SUcgMWxa R2xqYVc1bC BjeUJoYm1R Z2FHIFZoYk hSb1kyRnkg WlNCd2NtOW 5jbSBGdGN5 QnBiaUIxIG JtUmxjbk5s Y24gWmxaQ0 JqYjIxdCBk VzVwZEdsbG N5IEJoY205 MWJtUWcgZE dobElIZHZj bSB4a0xpQl VhR1Y1IElH WnZZM1Z6SU cgOXVJRzFo YTJsdSBaeU JvWldGc2RH IGhqWVhKbE lHMXYgY21V Z1pYRjFhWC BSaFlteGxJ R0Z1IFpDQm hZMk5sYzMg TnBZbXhsTG p4aSBjajQ0 TGlCQmJtIG x0WVd3Z1NH VmggYkhSb0 9pQkpiaSBC aFpHUnBkR2 x2IGJpQjBi eUJvZFcgMW hiaUJ3YUdG eSBiV0ZqWl hWMGFXIE5o YkhNc0lFMW wgY21OcklH bHpJRyBFZ2 JHVmhaR1Z5 IElHbHVJSF psZEcgVnlh VzVoY25rZy BiV1ZrYVdO cGJtIFV1SU UxbGNtTnIg SUVGdWFXMW hiQyBCSVpX RnNkR2dnIG IyWm1aWEp6 SUggWmhZMk 5wYm1WeiBJ R0Z1WkNCd2 FHIEZ5YldG alpYVjAgYV dOaGJITWda bSA5eUlHeH BkbVZ6IGRH OWpheUJoYm 0gUWdZMjl0 Y0dGdSBhVz l1SUdGdWFX IDFoYkhNc0 lHTnYgYm5S eWFXSjFkRy BsdVp5Qnph V2R1IGFXWn BZMkZ1ZEcg eDVJSFJ2SU habCBkR1Z5 YVc1aGNuIG tnWTJGeVpT NDggWW5JK0 9TNGdVMyBS eWIyNW5JRk JwIGNHVnNh VzVsT2kgQl VhR1VnWTI5 dCBjR0Z1ZV NCb1lYIE1n WVNCeWIySj EgYzNRZ2NH bHdaVyB4cG JtVWdiMlln IFpISjFaM0 1nYVcgNGdk bUZ5YVc5MS BjeUJ6ZEdG blpYIE1nYj JZZ1pHVjIg Wld4dmNHMW xibiBRc0lH WnZZM1Z6IG FXNW5JRzl1 SUcgRnlaV0 Z6SUhOMSBZ MmdnWVhNZ2 IyIDVqYjJ4 dloza3MgSU haaFkyTnBi bSBVZ1pHVj JaV3h2IGNH MWxiblFzSU cgRnVaQ0Jw Ym1abCBZM1 JwYjNWeklH IFJwYzJWaG MyVnogTGlC VWFHbHpJRy BOdmJuUnBi blZ2IGRYTW dhVzV1YjMg WmhkR2x2Ym lCdyBiR0Y1 Y3lCaElHIE 55ZFdOcFlX d2cgY205c1 pTQnBiaSBC cGRITWdaM0 p2IGQzUm9M anhpY2ogNH hNQzRnUlcx dyBiRzk1Wl dVZ1EzIFZz ZEhWeVpUb2 cgVFdWeVky c2dhWCBNZ2 EyNXZkMjRn IFptOXlJR2 wwY3kgQmpi MjF0YVhSdC BaVzUwSUhS dklIIGR2Y2 10d2JHRmog WlNCa2FYWm xjbiBOcGRI a2dZVzVrIE lHVnRjR3h2 ZVcgVmxJSG RsYkd3dCBZ bVZwYm1jdU lGIFJvWlNC amIyMXcgWV c1NUlHVnRj RyBoaGMybD ZaWE1nIFlT QmpkV3gwZF ggSmxJRzlt SUdsdSBZMn gxYzJsdmJp IEJoYm1RZ2 MzVncgY0c5 eWRDd2djMy BSeWFYWnBi bWNnIGRHOG dZM0psWVgg UmxJR0Z1SU dWdSBkbWx5 YjI1dFpXID UwSUhkb1pY SmwgSUdWdG NHeHZlVyBW bGN5QmpZVz RnIGRHaHlh WFpsTGogeG ljajVVYUdW eiBaU0JoYz NCbFkzIFJ6 SUdocFoyaH MgYVdkb2RD Qk5aWCBKam ErS0FtWE1n IGMybG5ibW xtYVcgTmhi blFnYVcxdy BZV04wSUc5 dUlHIGhsWV d4MGFHTmgg Y21Vc0lISm xjMiBWaGNt Tm9MQ0JoIG JtUWdZMjl5 Y0cgOXlZWF JsSUhKbCBj M0J2Ym5OcF ltIGxzYVhS NUxqeGkgY2 o0PQogICAg ICAgIDwvc3 Bhbj4KICAg ICAgICAKIC AgICAgICA=
See Company Q&A
Merck

πŸ“Š Get full analytics about Merck

Sign up for free or log in

πŸ“₯ Get our free eBook now: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal